Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Review Article

Potential of Nanoparticles in Combating Candida Infections

Author(s): Faizan Abul Qais, Mohd Sajjad Ahmad Khan, Iqbal Ahmad* and Abdullah Safar Althubiani

Volume 16, Issue 5, 2019

Page: [478 - 491] Pages: 14

DOI: 10.2174/1570180815666181015145224

Price: $65

Abstract

Aims: The aim of this review is to survey the recent progress made in developing the nanoparticles as antifungal agents especially the nano-based formulations being exploited for the management of Candida infections.

Discussion: In the last few decades, there has been many-fold increase in fungal infections including candidiasis due to the increased number of immunocompromised patients worldwide. The efficacy of available antifungal drugs is limited due to its associated toxicity and drug resistance in clinical strains. The recent advancements in nanobiotechnology have opened a new hope for the development of novel formulations with enhanced therapeutic efficacy, improved drug delivery and low toxicity.

Conclusion: Metal nanoparticles have shown to possess promising in vitro antifungal activities and could be effectively used for enhanced and targeted delivery of conventionally used drugs. The synergistic interaction between nanoparticles and various antifungal agents have also been reported with enhanced antifungal activity.

Keywords: Antifungal, Candida albicans, candidiasis, nanoparticles, synergy, nanobiotechnology.

Graphical Abstract

[1]
Sardi, J.C.O.; Scorzoni, L.; Bernardi, T.; Fusco-Almeida, A.M.; Giannini, M.M. Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J. Med. Microbiol., 2013, 62(1), 10-24.
[2]
Shao, P.L.; Huang, L.M.; Hsueh, P.R. Recent advances and challenges in the treatment of invasive fungal infections. Int. J. Antimicrob. Agents, 2007, 30(6), 487-495.
[3]
Blanco, J.L.; Garcia, M.E. Immune response to fungal infections. Vet. Immunol. Immunopathol., 2008, 125(1), 47-70.
[4]
Wisplinghoff, H.; Bischoff, T.; Tallent, S.M.; Seifert, H.; Wenzel, R.P.; Edmond, M.B. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis., 2004, 39(3), 309-317.
[5]
Pfaller, M.A.; Diekema, D.J. Epidemiology of invasive candidiasis: A persistent public health problem. Clin. Microbiol. Rev., 2007, 20(1), 133-163.
[6]
Prasad, R.; Shah, A.H.; Rawal, M.K. Antifungals: Mechanism of action and drug resistance. Yeast Membrane Trans., 2016, 327-349.
[7]
Han, S.; Kim, J.; Yim, H.; Hur, J.; Song, W.; Lee, J.; Jeon, S.; Hong, T.; Woo, H.; Yim, D.S. A Population Pharmacokinetic Analysis of Fluconazole to Predict Therapeutic Outcome in Burn Patients with Candida Infection. Antimicrob. Agents Chemother., 2012, AAC-01372.
[8]
Sarkar, S.; Uppuluri, P.; Pierce, C.G.; Lopez-Ribot, J.L. In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilms. Antimicrob. Agents Chemother., 2014, 58(2), 1183-1186.
[9]
Basha, B.N.; Prakasam, K.; Goli, D. Formulation and evaluation of gel containing fluconazole-antifungal agent. Int. J. Drug Dev. Res., 2011, 3(4), 109-128.
[10]
Araujo, R.; Espinel-Ingroff, A. Antifungal resistance: Cellular and molecular mechanisms; Combat. Fungal Infect, 2010, pp. 125-145.
[11]
Khan, M.S.A.; Ahmad, I.; Aqil, F.; Owais, M.; Shahid, M.; Musarrat, J. Virulence and pathogenicity of fungal pathogens with special reference to Candida albicans; Combating. Fungal Infect, 2010, pp. 21-45.
[12]
Zhang, L.; Keogh, S.; Rickard, C.M. Reducing the risk of infection associated with vascular access devices through nanotechnology: a perspective. Int. J. Nanomed, 2013, 8, 4453.
[13]
Akbari, F.; Kjellerup, B.V. Elimination of bloodstream infections associated with Candida albicans biofilm in intravascular catheters. Pathogens, 2015, 4(3), 457-469.
[14]
Gu, W.; Guo, D.; Zhang, L.; Xu, D.; Sun, S. The synergistic effect of azoles and fluoxetine against resistant Candida albicans strains is attributed to attenuating fungal virulence. Antimicrob. Agents Chemother., 2016, 60(10), 6179-6188.
[15]
Liu, S.; Hou, Y.; Chen, X.; Gao, Y.; Li, H.; Sun, S. Combination of fluconazole with non-antifungal agents: A promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery. Int. J. Antimicrob. Agents, 2014, 43(5), 395-402.
[16]
Kyle, A.A.; Dahl, M.V. Topical therapy for fungal infections. Am. J. Clin. Dermatol., 2004, 5(6), 443-451.
[17]
Güngör, S.; Erdal, M.S.; Aksu, B. New formulation strategies in topical antifungal therapy. J. Cosmet. Dermatol. Sci. App., 2013, 3(01), 56-65.
[18]
Dismukes, W.E. Introduction to antifungal drugs. Clinic. Infect. Dis., 2000, 30(4), 653-657.
[19]
Walsh, T.J.; Viviani, M.A.; Arathoon, E.; Chiou, C.; Ghannoum, M.; Groll, A.H.; Odds, F.C. New targets and delivery systems for antifungal therapy. Med. Mycol., 2000, 38(sup1), 335-347.
[20]
Khatry, S.; Sirish, N.S.; Sadanandam, M. Novel drug delivery systems for antifungal therapy. Int. J. Pharm. Pharmaceut. Sci., 2010, 2(4), 6-9.
[21]
Yah, C.S.; Simate, G.S. Nanoparticles as potential new generation broad spectrum antimicrobial agents. DARU J. Pharmaceut. Sci., 2015, 23(1), 43.
[22]
Dar, M.A.; Ingle, A.; Rai, M. Enhanced antimicrobial activity of silver nanoparticles synthesized by Cryphonectria sp. evaluated singly and in combination with antibiotics. Nanomed. Nanotech. Biol. Med., 2013, 9(1), 105-110.
[23]
Bhowmik, Ram. A.S.A.; Gowda, D.V.; Singh, A.; Srivastava1, A.; Osmani, R.A.M. Recent trends and advances in fungal drug delivery. J. Chem. Pharmaceut. Res., 2016, 8(4), 169-178.
[24]
De Jong, W.H.; Borm, P.J. Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomedicine, 2008, 3(2), 133.
[25]
Zazo, H.; Colino, C.I.; Lanao, J.M. Current applications of nanoparticles in infectious diseases. J. Control. Release, 2016, 224, 86-102.
[26]
Zia, Q.; Farzuddin, M.; Ansari, M.A.; Alam, M.; Ali, A.; Ahmad, I., &; Owais, M. Novel drug delivery systems for antifungal compounds; Combating. Fungal Infect, 2010, pp. 485-528.
[27]
Kim, K.J.; Sung, W.S.; Moon, S.K.; Choi, J.S.; Kim, J.G.; Lee, D.G. Antifungal effect of silver nanoparticles on dermatophytes. J. Microbiol. Biotechnol., 2008, 18(8), 1482-1484.
[28]
Panáček, A.; Kolář, M.; Večeřová, R.; Prucek, R.; Soukupová, J.; Kryštof, V.; Hamalb, P.; Zbořila, R.; Kvítek, L. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials, 2009, 30(31), 6333-6340.
[29]
Gajbhiye, M.; Kesharwani, J.; Ingle, A.; Gade, A.; Rai, M. Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole. Nanomed. Nanotechnol. Biol. Med., 2009, 5(4), 382-386.
[30]
Kandile, N.G.; Zaky, H.T.; Mohamed, M.I.; Mohamed, H.M. Silver nanoparticles effect on antimicrobial and antifungal activity of new heterocycles. Bullet. Korean Chem. Soc., 2010, 31(12), 3530-3538.
[31]
Monteiro, D.R.; Gorup, L.F.; Silva, S.; Negri, M.; de Camargo, E.R.; Oliveira, R.; Barbosa, D.D.; Henriques, M. Silver colloidal nanoparticles: Antifungal effect against adhered cells and biofilms of Candida albicans and Candida glabrata. Biofouling, 2011, 27(7), 711-719.
[32]
Xu, Y.; Gao, C.; Li, X.; He, Y.; Zhou, L.; Pang, G.; Sun, S. In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi. J. Ocular. Pharmacol. Therapeut., 2013, 29(2), 270-274.
[33]
Puišo, J.; Jonkuvienė, D.; Mačionienė, I.; Šalomskienė, J.; Jasutienė, I.; Kondrotas, R. Biosynthesis of silver nanoparticles using lingonberry and cranberry juices and their antimicrobial activity. Colloid Surf. B Biointerfaces, 2014, 121, 214-221.
[34]
Sanjenbam, P.; Gopal, J.V.; Kannabiran, K. Anticandidal activity of silver nanoparticles synthesized using Streptomyces sp. VITPK1. J. Mycol. Méd. J. Med. Mycol., 2014, 24(3), 211-219.
[35]
Suyana, P.; Kumar, S.N.; Madhavan, N.; Kumar, B.D.; Nair, B.N.; Mohamed, A.P.; Warrier, K.G. Hareesh, U.S. Reactive oxygen species (ROS) mediated enhanced anti-candidal activity of ZnS–ZnO nanocomposites with low inhibitory concentrations. RSC Adv, 2015, 5(94), 76718-76728.
[36]
Ashajyothi, C.; Prabhurajeshwar, C.; Handral, H.K.; Kelmani, C. Investigation of antifungal and anti-mycelium activities using biogenic nanoparticles: an eco-friendly approach. Environ. Nanotechnol. Monit. Manag., 2016, 5, 81-87.
[37]
Moazeni, M.; Kelidari, H.R.; Saeedi, M.; Morteza-Semnani, K.; Nabili, M.; Gohar, A.A.; Akbari, J.; Lotfali, E.; Nokhodchi, A. Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system. Colloids Surf. B Biointerfaces, 2016, 142, 400-407.
[38]
Pfaller, M.A. Antifungal drug resistance: Mechanisms, epidemiology, and consequences for treatment. Am. J. Med., 2012, 125(1), S3-S13.
[39]
Szweda, P.; Gucwa, K.; Kurzyk, E.; Romanowska, E.; Dzierżanowska-Fangrat, K.; Jurek, A.Z.; Kuś, P.M.; Milewski, S. Essential oils, silver nanoparticles and propolis as alternative agents against fluconazole resistant Candida albicans, Candida glabrata and Candida krusei clinical isolates. Ind. J. Microbiol., 2015, 55(2), 175-183.
[40]
Vaghasiya, H.; Kumar, A.; Sawant, K. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. Eur. J. Pharmaceut. Sci., 2013, 49(2), 311-322.
[41]
Bonilla, J.J.A.; Guerrero, D.J.P.; Suárez, C.I.S.; López, C.C.O. Sáez, R.G.T. In vitro antifungal activity of silver nanoparticles against fluconazole-resistant Candida species. World J. Microbiol. Biotechnol., 2015, 31(11), 1801-1809.
[42]
Alimehr, S.; Abad, H.S.E.; Shahverdi, A.; Hashemi, J.; Zomorodian, K.; Moazeni, M.; Vosoghian, S.; Rezaie, S. Comparison of difference between fluconazole and silver nanoparticles in antimicrobial effect on fluconazole-resistant candida albicans strains. Arch. Ped. Infect. Dis., 2015, 3(2), e21481.
[43]
Jalal, M.; Ansari, M.A.; Shukla, A.K.; Ali, S.G.; Khan, H.M.; Pal, R.; Alam, J.; Cameotra, S.S. Green synthesis and antifungal activity of Al2O3 NPs against fluconazole-resistant Candida spp isolated from a tertiary care hospital. RSC Adv, 2016, 6(109), 107577-107590.
[44]
Longhi, C.; Santos, J.P.; Morey, A.T.; Marcato, P.D.; Durán, N.; Pinge-Filho, P.; Nakazato, G.; Yamada-Ogatta, S.F.; Yamauchi, L.M. Combination of fluconazole with silver nanoparticles produced by Fusarium oxysporum improves antifungal effect against planktonic cells and biofilm of drug-resistant Candida albicans. Sabouraudia, 2015, 54(4), 428-432.
[45]
Lee, J.; Kim, K.J.; Sung, W.S.; Kim, J.G.; Lee, D.G. The silver nanoparticle (nano-Ag): A new model for antifungal agents; Silver Nanopart, 2010, pp. 295-308.
[46]
Kim, K.J.; Sung, W.S.; Suh, B.K.; Moon, S.K.; Choi, J.S.; Kim, J.G.; Lee, D.G. Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals, 2009, 22(2), 235-242.
[47]
Chwalibog, A.; Sawosz, E.; Hotowy, A.; Szeliga, J.; Mitura, S.; Mitura, K.; Grodzik, M.; Orlowski, P.; Sokolowska, A. Visualization of interaction between inorganic nanoparticles and bacteria or fungi. Int. J. Nanomed, 2010, 5(1), 1085-1094.
[48]
Feng, Q.L.; Wu, J.; Chen, G.Q.; Cui, F.Z.; Kim, T.N.; Kim, J.O. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J. Biomed. Material. Res., 2000, 52(4), 662-668.
[49]
Lok, C.N.; Ho, C.M.; Chen, R.; He, Q.Y.; Yu, W.Y.; Sun, H.; Tam, P.K.; Chiu, J.F.; Che, C.M. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J. Proteome Res., 2006, 5(4), 916-924.
[50]
Yang, E.J.; Jang, J.; Kim, S.; Choi, I.H. Silver nanoparticles as a smart antimicrobial agent. J. Bacteriol. Virol., 2012, 42(2), 177-179.
[51]
Zawrah, M.F.; El-Moez, S.A.; Center, D. Antimicrobial activities of gold nanoparticles against major foodborne pathogens. Life Sci. J., 2011, 8(4), 37-44.
[52]
Monteiro, D.R.; Silva, S.; Negri, M.; Gorup, L.F.; Camargo, E.R.; Oliveira, R.; Barbosa, D.B.; Henriques, M. Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. Mycoses, 2013, 56(6), 672-680.
[53]
Vazquez-Muñoz, R.; Avalos-Borja, M.; Castro-Longoria, E. Ultrastructural analysis of Candida albicans when exposed to silver nanoparticles. PLoS One, 2014, 9(10), e108876.
[54]
Ogar, A.; Tylko, G.; Turnau, K. Antifungal properties of silver nanoparticles against indoor mould growth. Sci. Total Envir., 2015, 521, 305-314.
[55]
Hwang, I.S.; Hwang, J.H.; Choi, H.; Kim, K.J.; Lee, D.G. Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved. J. Med. Microbiol., 2012, 61(12), 1719-1726.
[56]
Kipp, J.E. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int. J. Pharm., 2004, 284(1), 109-122.
[57]
Upadhyay, R.K. Drug delivery systems, CNS protection, and the blood brain barrier. BioMed Res. Int., 2014, 2014, 37.
[http://dx.doi.org/10.1155/ 2014/869269]
[58]
Alizadeh, H.; Salouti, M.; Shapouri, R. Bactericidal effect of silver nanoparticles on intramacrophage brucella abortus 544. Jundishapur J. Microbiol., 2014, 7(3), e9039.
[59]
Yah, C.S.; Simate, G.S.; Iyuke, S.E. Nanoparticles toxicity and their routes of exposures. Pak. J. Pharmaceut. Sci., 2012, 25(2), 477-491.
[60]
Moghimi, S.M.; Hunter, A.C.; Murray, J.C. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev., 2001, 53(2), 283-318.
[61]
Niidome, T.; Yamagata, M.; Okamoto, Y.; Akiyama, Y.; Takahashi, H.; Kawano, T.; Katayama, Y.; Niidome, Y. PEG-modified gold nanorods with a stealth character for in vivo applications. J. Control. Release, 2006, 114(3), 343-347.
[62]
Gupta, A.K.; Gupta, M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials, 2005, 26(18), 3995-4021.
[63]
Seki, J.; Sonoke, S.; Saheki, A.; Fukui, H.; Sasaki, H.; Mayumi, T. A nanometer lipid emulsion, lipid nano-sphere (LNS®), as a parenteral drug carrier for passive drug targeting. Int. J. Pharmaceut., 2004, 273(1), 75-83.
[64]
Fang, C.; Shi, B.; Pei, Y.Y.; Hong, M.H.; Wu, J., &; Chen, H.Z. In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle size. Eur. J. Pharm. Sci., 2006, 27(1), 27-36.
[65]
Yang, W.; Wiederhold, N.P. Williams III, R.O. Drug delivery strategies for improved azole antifungal action. Exp Opin. Drug Deliv., 2008, 5(11), 1199-1216.
[66]
Cassano, R.; Ferrarelli, T.; Mauro, M.V.; Cavalcanti, P.; Picci, N.; Trombino, S. Preparation, characterization and in vitro activities evaluation of solid lipid nanoparticles based on PEG-40 stearate for antifungal drugs vaginal delivery. Drug Deliv., 2016, 23(3), 1037-1046.
[67]
Bianco, M.A.; Gallarate, M.; Trotta, M.; Battaglia, L. Amphotericin B loaded SLN prepared with the coacervation technique. J. Drug Deliv. Sci. Technol., 2010, 20(3), 187-191.
[68]
Gupta, M.; Vyas, S.P. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem. Physics. Lip, 2012, 165(4), 454-461.
[69]
Jain, S.; Valvi, P.U.; Swarnakar, N.K.; Thanki, K. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B. Mol. Pharmaceutics., 2012, 9(9), 2542-2553.
[70]
Santos, S.S.; Lorenzoni, A.; Ferreira, L.M.; Mattiazzi, J.; Adams, A.I.; Denardi, L.B.; Alves, S.H.; Schaffazick, S.R.; Cruz, L. Clotrimazole-loaded Eudragit® RS100 nanocapsules: Preparation, characterization and in vitro evaluation of antifungal activity against Candida species. Mater. Sci. Eng. C, 2013, 33(3), 1389-1394.
[71]
Shekhawat, P.B. Preparation and evaluation of clotrimazole nanostructured lipid carrier for topical delivery. Int. J. Pharm. Biosci., 2013, 4, 407-416.
[72]
Ravani, L.; Esposito, E.; Bories, C.; Lievin-Le Moal, V.; Loiseau, P.M.; Djabourov, M.; Cortesi, R. Bouchemal, K. Clotrimazole-loaded nanostructured lipid carrier hydrogels: Thermal analysis and in vitro studies. Int. J. Pharm., 2013, 454(2), 695-702.
[73]
Sanchez, D.A.; Schairer, D.; Tuckman-Vernon, C.; Chouake, J.; Kutner, A.; Makdisi, J.; Friedman, J.M.; Nosanchuk, J.D.; Friedman, A.J. Amphotericin B releasing nanoparticle topical treatment of Candida spp. in the setting of a burn wound. Nanomed. Nanotechnol. Biol. Med., 2014, 10(1), 269-277.
[74]
Yang, Z.; Chen, M.; Yang, M.; Chen, J.; Fang, W.; Xu, P. Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection. Int. J. Nanomed, 2014, 9, 327-336.
[75]
Tang, X.; Jiao, R.; Xie, C.; Xu, L.; Huo, Z.; Dai, J.; Qian, Y.; Xu, W.; Hou, W.; Wang, J.; Liang, Y. Improved antifungal activity of amphotericin B-loaded TPGS-b-(PCL-ran-PGA) nanoparticles. Int. J. Clin. Exp. Med., 2015, 8(4), 5150-5162.
[76]
Verma, P.; Ahuja, M. Optimization, characterization and evaluation of chitosan-tailored cubic nanoparticles of clotrimazole. Int. J. Biol. Macromol., 2015, 73, 138-145.
[77]
Pandurangan, D.K.; Bodagala, P.; Palanirajan, V.K.; Govindaraj, S. Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel. Int. J. Pharmaceut. Investig., 2016, 6(1), 56.
[78]
Souto, E.B.; Wissing, S.A.; Barbosa, C.M.; Müller, R.H. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Intig. J. Pharm., 2004, 278(1), 71-77.
[79]
Sanna, V.; Gavini, E.; Cossu, M.; Rassu, G.; Giunchedi, P. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in‐vitro characterization, ex‐vivo and in‐vivo studies. J. Pharm. Pharmacol., 2007, 59(8), 1057-1064.
[80]
Souto, E.B.; Müller, R.H. Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams. Die Pharmazie-An Int. J. Pharm. Sci., 2007, 62(7), 505-509.
[81]
Bhalekar, M.R.; Pokharkar, V.; Madgulkar, A.; Patil, N.; Patil, N. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech, 2009, 10(1), 289-296.
[82]
Chen, Y.C.; Liu, D.Z.; Liu, J.J.; Chang, T.W.; Ho, H.O.; Sheu, M.T. Development of terbinafine solid lipid nanoparticles as a topical delivery system. Int. J. Nanomed, 2012, 7, 4409-4418.
[83]
Samein, L.H. Preparation and evaluation of nystatin-loaded solid-lipid-nanoparticles for topical delivery. Asian J. Pharmaceut. Res., 2014, 4(1), 44-51.
[84]
Kumar, R.; Sinha, V.R. Solid lipid nanoparticle: An efficient carrier for improved ocular permeation of voriconazole. Drug Dev. Ind. Pharm., 2016, 42(12), 1956-1967.
[85]
Khare, A.; Singh, I.; Pawar, P.; Grover, K. Design and evaluation of voriconazole loaded solid lipid nanoparticles for ophthalmic application. J. Drug Deliv., 2016.
[http://dx.doi.org/10.1155/2016/6590361]
[86]
Nel, A.; Xia, T.; Mädler, L.; Li, N. Toxic potential of materials at the nanolevel. Science, 2006, 311(5761), 622-627.
[87]
Vecitis, C.D.; Zodrow, K.R.; Kang, S.; Elimelech, M. Electronic-structure-dependent bacterial cytotoxicity of single-walled carbon nanotubes. ACS Nano, 2010, 4(9), 5471-5479.
[88]
Aboulaich, A.; Tilmaciu, C.M.; Merlin, C.; Mercier, C.; Guilloteau, H.; Medjahdi, G.; Schneider, R. Physicochemical properties and cellular toxicity of (poly) aminoalkoxysilanes-functionalized ZnO quantum dots. Nanotechnology, 2012, 23(33), 335101.
[89]
Kirthi, A.V.; Rahuman, A.A.; Rajakumar, G.; Marimuthu, S.; Santhoshkumar, T.; Jayaseelan, C.; Velayutham, K. Acaricidal, pediculocidal and larvicidal activity of synthesized ZnO nanoparticles using wet chemical route against blood feeding parasites. Parasitol. Res., 2011, 109(2), 461-472.
[90]
Nuñez-Anita, R.E.; Acosta-Torres, L.S.; Vilar-Pineda, J.; Martínez-Espinosa, J.C.; de la Fuente-Hernández, J.; Castaño, V.M. Toxicology of antimicrobial nanoparticles for prosthetic devices. Int. J. Nanomed, 2014, 9, 3999-4006.
[91]
Navarro, E.; Piccapietra, F.; Wagner, B.; Marconi, F.; Kaegi, R.; Odzak, N.; Sigg, L.; Behra, R. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Envir. Sci. Technol., 2008, 42(23), 8959-8964.
[92]
Donaldson, K.; Aitken, R.; Tran, L.; Stone, V.; Duffin, R.; Forrest, G.; Alexander, A. Carbon nanotubes: A review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol. Sci., 2006, 92(1), 5-22.
[93]
Sayes, C.M.; Gobin, A.M.; Ausman, K.D.; Mendez, J.; West, J.L.; Colvin, V.L. Nano-C 60 cytotoxicity is due to lipid peroxidation. Biomaterials, 2005, 26(36), 7587-7595.
[94]
Hardman, R. A toxicologic review of quantum dots: Toxicity depends on physicochemical and environmental factors. Environ. Health Perspect., 2006, 114(2), 165-172.
[95]
Vandeputte, P.; Ferrari, S.; Coste, A.T. Antifungal resistance and new strategies to control fungal infections. Int. J. Microbiol., 2011, 2012, 26.
[http://dx.doi.org/10.1155/2012/713687]
[96]
Zoroddu, M.A.; Medici, S.; Ledda, A.; Nurchi, V.M.; Lachowicz, J.I.; Peana, M. Toxicity of nanoparticles. Curr. Med. Chem., 2014, 21, 3837-3853.
[97]
Mohapatra, S.C.; Tiwari, H.K.; Singla, M.; Rathi, B.; Sharma, A.; Mahiya, K.; Kumar, M.; Sinha, S.; Chauhan, S.S. Antimalarial evaluation of copper (II) nanohybrid solids: Inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum. JBIC J. Biol. Inorg. Chem., 2010, 15(3), 373-385.
[98]
Papp, I.; Sieben, C.; Ludwig, K.; Roskamp, M.; Böttcher, C.; Schlecht, S.; Herrmann, A.; Haag, R. Inhibition of influenza virus infection by multivalent sialic‐acid‐functionalized gold nanoparticles. Small, 2010, 6(24), 2900-2906.
[99]
Ahmed, F.; Santos, C.M.; Mangadlao, J.; Advincula, R.; Rodrigues, D.F. Antimicrobial PVK: SWNT nanocomposite coated membrane for water purification: Performance and toxicity testing. Water Res., 2013, 47(12), 3966-3975.
[100]
Uhm, S.H.; Lee, S.B.; Song, D.H.; Kwon, J.S.; Han, J.G.; Kim, K.N. Fabrication of bioactive, antibacterial TiO2 nanotube surfaces, coated with magnetron sputtered Ag nanostructures for dental applications. J. Nanosci. Nanotechnol., 2014, 14(10), 7847-7854.
[101]
Cooper, R.J.; Spitzer, N. Silver nanoparticles at sublethal concentrations disrupt cytoskeleton and neurite dynamics in cultured adult neural stem cells. Neurotoxicology, 2015, 48, 231-238.
[102]
Butani, D.; Yewale, C.; Misra, A. Topical Amphotericin B solid lipid nanoparticles: Design and development. Colloid Surf. B Biointerf, 2016, 139, 17-24.
[103]
Cakić, M.; Glišić, S.; Nikolić, G.; Nikolić, G.M.; Cakić, K.; Cvetinov, M. Synthesis, characterization and antimicrobial activity of dextran sulphate stabilized silver nanoparticles. J. Mol. Struct., 2016, 1110, 156-161.
[104]
Rajeshkumar, S.; Malarkodi, C.; Vanaja, M.; Annadurai, G. Anticancer and enhanced antimicrobial activity of biosynthesizd silver nanoparticles against clinical pathogens. J. Mol. Struct., 2016, 1116, 165-173.
[105]
Geethalakshmi, R.; Sarada, D.V.L. Characterization and antimicrobial activity of gold and silver nanoparticles synthesized using saponin isolated from Trianthema decandra L. Ind. Crops Prod., 2013, 51, 107-115.
[106]
Kanipandian, N.; Thirumurugan, R. A feasible approach to phyto-mediated synthesis of silver nanoparticles using industrial crop Gossypium hirsutum (cotton) extract as stabilizing agent and assessment of its in vitro biomedical potential. Ind. Crops Prod., 2014, 55, 1-10.
[107]
Prucek, R.; Tuček, J.; Kilianová, M.; Panáček, A.; Kvítek, L.; Filip, J.; Kolář, M.; Tománková, K.; Zbořil, R. The targeted antibacterial and antifungal properties of magnetic nanocomposite of iron oxide and silver nanoparticles. Biomaterials, 2011, 32(21), 4704-4713.
[108]
Li, C.; Wang, X.; Chen, F.; Zhang, C.; Zhi, X.; Wang, K.; Cui, D. The antifungal activity of graphene oxide–silver nanocomposites. Biomaterials, 2013, 34(15), 3882-3890.
[109]
Wani, I.A.; Ahmad, T. Size and shape dependant antifungal activity of gold nanoparticles: A case study of Candida. Colloid Surf. B Biointerf, 2013, 101, 162-170.
[110]
Ibrahim, H.M. Green synthesis and characterization of silver nanoparticles using banana peel extract and their antimicrobial activity against representative microorganisms. J. Radiat. Res. Appl. Sci., 2015, 8(3), 265-275.
[111]
Hameed, A.S.H.; Karthikeyan, C.; Kumar, V.S.; Kumaresan, S.; Sasikumar, S. Effect of Mg 2+, Ca 2+, Sr 2+ and Ba 2+ metal ions on the antifungal activity of ZnO nanoparticles tested against Candida albicans. Mater. Sci. Eng. C, 2015, 52, 171-177.
[112]
Netala, V.R.; Kotakadi, V.S.; Domdi, L.; Gaddam, S.A.; Bobbu, P.; Venkata, S.K.; Ghosh, S.B.; Tartte, V. Biogenic silver nanoparticles: Efficient and effective antifungal agents. Appl. Nanosci., 2016, 6(4), 475-484.
[113]
Khan, S.; Alam, F.; Azam, A.; Khan, A.U. Gold nanoparticles enhance methylene blue-induced photodynamic therapy:A novel therapeutic approach to inhibit Candida albicans biofilm. Int. J. Nanomed, 2012, 7, 3245-3257.
[114]
Paulo, C.S.; Vidal, M.; Ferreira, L.S. Antifungal nanoparticles and surfaces. Biomacromolecules., 2010, 11(10), 2810-2817.
[115]
Nasrollahi, A.; Pourshamsian, K.H.; Mansourkiaee, P. Antifungal activity of silver nanoparticles on some of fungi. Int. J. Nano Dimension., 2011, 1(3), 233-239.
[116]
MR K.P.; Umamaheswari, K.; Sharmili, A.; Rajendiran, N. Antifungal activity of silver nanoparticles synthesized using phenylalanine conjugated cholic acid salts & tyrosine conjugated cholic acid salts against candida species. Int. J. Innov. Res. Dev., 2014, 3(6), 244-248.
[117]
Karimiyan, A.; Najafzadeh, H.; Ghorbanpour, M.; Hekmati-Moghaddam, S.H. Antifungal effect of magnesium oxide, zinc oxide, silicon oxide and copper oxide nanoparticles against Candida albicans. Zahedan J. Res. Med. Sci., 2015, 17(10), e2179.
[118]
Hamid, S.; Zainab, S.; Faryal, R.; Ali, N.; Sharafat, I. Inhibition of secreted aspartyl proteinase activity in biofilms of Candida species by mycogenic silver nanoparticles. Artificial. Cells Nanomed. Biotechnol., 2017, 1-7.
[http://dx.doi.org/10.1080/21691401.2017.1328688]
[119]
Selvaraj, M.; Pandurangan, P.; Ramasami, N.; Rajendran, S.B.; Sangilimuthu, S.N.; Perumal, P. Highly potential antifungal activity of quantum-sized silver nanoparticles against Candida albicans. Appl. Biochem. Biotechnol., 2014, 173(1), 55-66.
[120]
Abdehgah, I.B.; Khodav, A.; Shamsazar, A.; Negahdary, M.; Jafarzadeh, M.; Rahimi, G. In vitro antifungal effects of biosynthesized silver nanoparticle by Candida albicans against Candida glabrata. Biomed. Res., 2017, 28(7), 2870-2876.
[121]
Seddighi, N.S.; Salari, S.; Izadi, A.R. Evaluation of antifungal effect of iron-oxide nanoparticles against different Candida species. IET Nanobiotechnol., 2017, 11(7), 883-888.
[122]
Khatoon, N.; Mishra, A.; Alam, H.; Manzoor, N.; Sardar, M. Biosynthesis, characterization, and antifungal activity of the silver nanoparticles against pathogenic Candida species. Bio. Nano. Sci., 2015, 5(2), 65-74.
[123]
Lara, H.H.; Romero-Urbina, D.G.; Pierce, C.; Lopez-Ribot, J.L.; Arellano-Jiménez, M.J.; Jose-Yacaman, M. Effect of silver nanoparticles on Candida albicans biofilms: An ultrastructural study. J. Nanobiotechnol, 2015, 13(1), 91-93.
[124]
Ashour, S.M. Silver nanoparticles as antimicrobial agent from Kluyveromyces marxianus and Candida utilis. Int. J. Curr. Microbiol. Appl. Sci., 2014, 3(8), 384-396.
[125]
Qasim, M.; Singh, B.R.; Naqvi, A.H.; Paik, P.; Das, D. Silver nanoparticles embedded mesoporous SiO2 nanosphere: An effective anticandidal agent against Candida albicans 077. Nanotechnology, 2015, 26(28), 285102.
[126]
Samrat, K.; Nikhil, N.S.; Namasivamyam, S.K.R.; Sharath, R.; Chandraprabha, M.N.; Harish, B.G.; Muktha, H.; Kashyap, R.G. Evaluation of improved antifungal activity of fluconazole-silver nanoconjugate against pathogenic fungi. Materials Today: Proceed., 2016, 3(6), 1958-1967.
[127]
Mohanty, B.; Majumdar, D.K.; Mishra, S.K.; Panda, A.K.; Patnaik, S. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery. Pharm. Dev. Technol., 2015, 20(4), 458-464.
[128]
Jain, S.; Jain, S.; Khare, P.; Gulbake, A.; Bansal, D.; Jain, S.K. Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Deliv., 2010, 17(6), 443-451.
[129]
Italia, J.L.; Sharp, A.; Carter, K.C.; Warn, P.; Kumar, M.R. Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™. PLoS One, 2011, 6(10), e25744.
[130]
Dizaj, S.M.; Lotfipour, F.; Barzegar-Jalali, M.; Zarrintan, M.H.; Adibkia, K. Antimicrobial activity of the metals and metal oxide nanoparticles. Mater. Sci. Eng. C, 2014, 44, 278-284.

© 2025 Bentham Science Publishers | Privacy Policy
Request history8.2.27PHP Version310msRequest Duration28MBMemory UsageGET article/{article_id}/{param?}Route
  • warninglog[04:36:45] LOG.warning: Optional parameter $article_id declared before required parameter $request i...
  • warninglog[04:36:45] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[04:36:45] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • Booting (127ms)time
  • Application (183ms)time
  • 1 x Application (58.97%)
    183ms
    1 x Booting (41.03%)
    127ms
    10 templates were rendered
    • articlearticle.blade.php#?blade
    • includes.article_referencearticle_reference.blade.php#?blade
    • export_citation_formexport_citation_form.blade.php#?blade
    • includes.article_bottom_bannerarticle_bottom_banner.blade.php#?blade
    • includes.journal_rightmenujournal_rightmenu.blade.php#?blade
    • layouts.appapp.blade.php#?blade
    • layouts._login_access_login_access.blade.php#?blade
    • layouts._header_header.blade.php#?blade
    • layouts._main_menu_main_menu.blade.php#?blade
    • layouts._footer_menu_footer_menu.blade.php#?blade
    uri
    GET article/{article_id}/{param?}
    middleware
    web, check_user_access
    controller
    App\Http\Controllers\ArticleController@GetArticleDetails
    namespace
    App\Http\Controllers
    where
    as
    article
    file
    app/Http/Controllers/ArticleController.php:1974-2510
    35 statements were executed, 2 of which were duplicates, 33 unique. Show only duplicated98.82ms
    • Connection Establishedalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 9. middleware::check_user_access:24
      • 10. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 11. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address (ip_address,visitor_agent,visitor_count, created_on,updated_on) VALUES ('873368187','',1,1740458205,1740458205) ON DUPLICATE KEY UPDATE visitor_count=visitor_count + 1, updated_on=1740458205
      1.21msalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 11. middleware::check_user_access:24
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address_detail (ip_address,visitor_url,visitor_count, created_on,updated_on) VALUES ('873368187','/article/93685',1,1740458205,1740458205)
      190μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#27
      Backtrace
      • 11. middleware::check_user_access:27
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_trail WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_corporate WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_token WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_trail WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_corporate WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_token WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_trail WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_corporate WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_token WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_trail WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_corporate WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_token WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_trail WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_corporate WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_token WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_disease_corporate WHERE to_ip >= 873368187 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 873368187) limit 1
      11.94msalphaeurekaselec_live_10_06_2022UserAccess.php#784
      Bindings
      • 0: 873368187
      • 1: 873368187
      • 2: 873368187
      • 3: 873368187
      • 4: 873368187
      • 5: 873368187
      • 6: 873368187
      • 7: 873368187
      • 8: 873368187
      • 9: 873368187
      • 10: 873368187
      • 11: 873368187
      • 12: 873368187
      • 13: 873368187
      • 14: 873368187
      • 15: 873368187
      Backtrace
      • 14. app/Models/UserAccess/UserAccess.php:784
      • 15. middleware::check_user_access:114
      • 16. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 18. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
    • SELECT at.type_name, p.copyright, p.publisher_location,m.month,y.year, a.publish_on, a.nid article_nid,a.article_id, a.pmid, a.issue_id, a.title, a.abstract,a.podcast,a.altmetric_score,a.altmetric_url,a.kudos_url, a.page_count, a.first_page, a.elocator, a.last_page, i.publication_date, a.file_name, a.file_path, a.doi, a.is_epub,a.epub_type, a.volume_id, a.is_uploaded, a.editor_choice, a.is_epub, j.image_file_name, a.article_no, a.art_type AS article_type, a.supplementary_filename,a.html_filename,a.prc_filename,a.epub_filename, a.graph_abs_lg_filename, a.graph_abs_sm_filename, a.oa_image_lg_filename, a.oa_image_sm_filename, j.journal_banner,a.animated_abstract,a.erratum_in,a.erratum_for, (CASE WHEN a.issue_id =0 THEN j.epub_price ELSE j.price END) AS sell_price, j.epub_price, j.nid AS jour_nid, j.title AS journal_title, j.issn, j.eissn,j.journal_id, j.subtitle AS jour_subtitle, v.volume_id,v.volume_name AS volume, v.year_id, i.title AS issue, i.month_id ,i.type issue_type, j.subtitle,j.formerly_title, ac.subtitle AS epub_title,a.crossmark_enabled,a.text_mining_urls,a.license_urls,a.created, a.receivedate, a.revisedate, a.acceptdate,js.js_title FROM article a LEFT JOIN article_section ac ON a.is_epub = ac.art_sec_id LEFT JOIN journal_section js ON a.js_id = js.js_id LEFT JOIN article_type at ON a.art_type = at.art_type_id LEFT JOIN issue i ON a.issue_id = i.issue_id LEFT JOIN month m ON m.id = i.month_id LEFT JOIN volume v ON v.volume_id = a.volume_id INNER JOIN year y ON y.id = v.year_id INNER JOIN journal j ON j.journal_id = a.journal_id INNER JOIN publisher p ON p.publisher_id = j.publisher_id WHERE a.article_id=93685
      780μsalphaeurekaselec_live_10_06_2022Article.php#408
      Backtrace
      • 11. app/Models/Article.php:408
      • 12. app/Http/Controllers/ArticleController.php:2515
      • 13. app/Http/Controllers/ArticleController.php:2035
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `journal` where `journal_id` = 57 limit 1
      820μsalphaeurekaselec_live_10_06_2022Journal.php#64
      Bindings
      • 0: 57
      Backtrace
      • 14. app/Models/Journal.php:64
      • 15. app/Http/Controllers/ArticleController.php:2516
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=57) and sj.journal_id!=57 group by `j`.`nid`) as `aggregate_table`
      1.07msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 16. app/Models/Subject.php:200
      • 17. app/Http/Controllers/ArticleController.php:2517
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=57) and sj.journal_id!=57 group by `j`.`nid` order by `j`.`journal_id` asc limit 10 offset 0
      930μsalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 14. app/Models/Subject.php:200
      • 15. app/Http/Controllers/ArticleController.php:2517
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=57) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid`) as `aggregate_table`
      1.26msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 16. app/Models/Subject.php:220
      • 17. app/Http/Controllers/ArticleController.php:2518
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=57) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid` order by `v`.`ebook_volume_id` desc limit 10 offset 0
      1.25msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 14. app/Models/Subject.php:220
      • 15. app/Http/Controllers/ArticleController.php:2518
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `keywords` where `article_id` = '93685'
      260μsalphaeurekaselec_live_10_06_2022Keywords.php#43
      Bindings
      • 0: 93685
      Backtrace
      • 13. app/Models/Keywords.php:43
      • 14. app/Http/Controllers/ArticleController.php:2519
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `article_citation` where `article_id` = '93685'
      4.93msalphaeurekaselec_live_10_06_2022Article.php#1570
      Bindings
      • 0: 93685
      Backtrace
      • 13. app/Models/Article.php:1570
      • 14. app/Http/Controllers/ArticleController.php:2520
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT(au.last_name, IFNULL(CONCAT(' ', au.initials), ''), ' ', au.first_name) AS authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs, CONCAT_WS(' ',au.first_name, IFNULL(CONCAT(' ', au.initials), ''), IFNULL(CONCAT(' ', au.last_name), '')) as authorsmodal , `au`.*, `af`.`ror_id`, `af`.`institution`, `af`.`department`, `af`.`country`, `af`.`city`, `af`.`address`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `author` as `au` left join `author_affiliation` as `af` on `au`.`author_id` = `af`.`author_id` where `au`.`article_id` = '93685' group by `au`.`author_id` order by `au`.`article_id` asc, `au`.`sequence` asc
      3.37msalphaeurekaselec_live_10_06_2022Author.php#86
      Bindings
      • 0: 93685
      Backtrace
      • 13. app/Models/Author.php:86
      • 14. app/Http/Controllers/ArticleController.php:2533
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      210μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2535
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `subtitle` from `journal` where `continues_publication_journal` = 1
      430μsalphaeurekaselec_live_10_06_2022Article.php#1960
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/Article.php:1960
      • 14. app/Http/Controllers/ArticleController.php:2062
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • Select j.subtitle, v.volume_id as volume_id,v.year_id,y.year as year,v.volume_name, v.total_no_of_issues, i.issue_id as issue_id,i.title as issue, i.publication_date as issue_pub_date from journal j join volume v on j.journal_id = v.journal_id join issue i on v.volume_id = i.volume_id join article a on a.issue_id = i.issue_id join year y on v.year_id = y.id where j.journal_id = 57 and i.is_uploaded = 1 order by v.volume_name+0 desc, i.title+0 desc limit 1
      27.09msalphaeurekaselec_live_10_06_2022Issue.php#298
      Backtrace
      • 11. app/Models/Issue.php:298
      • 12. app/Http/Controllers/ArticleController.php:2068
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 1 and a.journal_id = 57 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      10.05msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2070
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 4 and a.journal_id = 57 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      9.46msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2071
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select pdf, html, epub, prc from `article_metrics` where `article_id` = 93685 limit 1
      290μsalphaeurekaselec_live_10_06_2022Article.php#744
      Bindings
      • 0: 93685
      Backtrace
      • 14. app/Models/Article.php:744
      • 15. app/Http/Controllers/ArticleController.php:2091
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from content_by_diseases where content_id = 93685 and content_type = 'article' order by status desc limit 1
      280μsalphaeurekaselec_live_10_06_2022Article.php#751
      Backtrace
      • 11. app/Models/Article.php:751
      • 12. app/Http/Controllers/ArticleController.php:2094
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `node_meta` where `nid` = 166260 limit 1
      230μsalphaeurekaselec_live_10_06_2022Meta.php#30
      Bindings
      • 0: 166260
      Backtrace
      • 14. app/Models/Meta.php:30
      • 15. app/Http/Controllers/ArticleController.php:2101
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      260μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2108
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `tbl_ht_submission` as `h` where `h`.`subtitle` = 'LDDD' and (h.proposal_closing_date = 0 OR TO_DAYS(FROM_UNIXTIME(h.proposal_closing_date)) >= TO_DAYS(NOW())) order by `h`.`manuscript` asc
      280μsalphaeurekaselec_live_10_06_2022Article.php#2025
      Bindings
      • 0: LDDD
      Backtrace
      • 13. app/Models/Article.php:2025
      • 14. app/Http/Controllers/ArticleController.php:2112
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '93685' and content_type = 'a' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      390μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2186
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '9047' and content_type = 'i' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      330μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2207
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '2491' and content_type = 'v' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      310μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2231
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873368187 and j.to_ip >=873368187 )) and ((j.from_date <= 1740458205 and j.to_date >= 1740458205 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2491) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873368187 and j.to_ip >=873368187 )) and ((j.from_date <= 1740458205 and j.to_date >= 1740458205 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2491) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873368187 and j.to_ip >=873368187 )) and ((j.from_date <= 1740458205 and j.to_date >= 1740458205 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2491)
      11.91msalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2272
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873368187 and j.to_ip >=873368187 )) and ((j.from_date <= 1740458205 and j.to_date >= 1740458205 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 9047) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873368187 and j.to_ip >=873368187 )) and ((j.from_date <= 1740458205 and j.to_date >= 1740458205 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 9047) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873368187 and j.to_ip >=873368187 )) and ((j.from_date <= 1740458205 and j.to_date >= 1740458205 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 9047)
      960μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2297
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873368187 and j.to_ip >=873368187 )) and ((j.from_date <= 1740458205 and j.to_date >= 1740458205 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 93685) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873368187 and j.to_ip >=873368187 )) and ((j.from_date <= 1740458205 and j.to_date >= 1740458205 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 93685) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 873368187 and j.to_ip >=873368187 )) and ((j.from_date <= 1740458205 and j.to_date >= 1740458205 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 93685)
      840μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2329
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `first_page` < '478' and is_uploaded = 1 and issue_id = 9047 order by cast(first_page as SIGNED) desc limit 1
      710μsalphaeurekaselec_live_10_06_2022Article.php#1819
      Bindings
      • 0: 478
      Backtrace
      • 14. app/Models/Article.php:1819
      • 15. app/Http/Controllers/ArticleController.php:2470
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `last_page` > '491' and is_uploaded = 1 and issue_id = 9047 order by cast(first_page as SIGNED) asc limit 1
      640μsalphaeurekaselec_live_10_06_2022Article.php#1831
      Bindings
      • 0: 491
      Backtrace
      • 14. app/Models/Article.php:1831
      • 15. app/Http/Controllers/ArticleController.php:2472
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `language_id` from `multilanguage` where `short_code` = 'en'
      220μsalphaeurekaselec_live_10_06_2022ArticleController.php#2497
      Bindings
      • 0: en
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2497
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `source_lang_label`, `target_lang_label` from `multilanguage_labels` where `target_lang_id` = 1
      230μsalphaeurekaselec_live_10_06_2022MultiLanguage.php#23
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/MultiLanguage.php:23
      • 14. app/Http/Controllers/ArticleController.php:2498
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `id` from `multilanguage_article` where `article_id` = 93685 limit 1
      3.84msalphaeurekaselec_live_10_06_2022ArticleController.php#2506
      Bindings
      • 0: 93685
      Backtrace
      • 16. app/Http/Controllers/ArticleController.php:2506
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 20. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 57 and `b`.`banner_from_date` <= 1740458205 and `b`.`banner_to_date` >= 1740458205 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.55msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 57
      • 3: 1740458205
      • 4: 1740458205
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select count(*) as aggregate from `uc_cart_products` where cart_id='ead92e0c4a049ec07c18b3d243ca3b89'
      300μsalphaeurekaselec_live_10_06_2022Cart.php#271
      Backtrace
      • 15. app/Models/Cart.php:271
      • 16. view::layouts._header:260
      • 18. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 20. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    App\Models\MultiLanguage
    1MultiLanguage.php#?
        _token
        y9w8k8zMnopb8xedSQfhab94v89NI5MCkqgj0tKl
        uc_cart_id
        ead92e0c4a049ec07c18b3d243ca3b89
        _previous
        array:1 [ "url" => "http://alpha.eurekaselect.com/article/93685" ]
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /article/93685
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:9 [ "cookie" => array:1 [ 0 => "wayfindertarget=eyJpdiI6InFuNW8rWC9zbDNHZUZZUGt6NGtNZGc9PSIsInZhbHVlIjoieTZMNTBlYk11RUhuQnRHdXZsVU1ZUFFyMHBoRTMyZFpqdHBCbDdvbUpGND0iLCJtYWMiOiI4YzI5ZDIyMGE4MzBlMzI0MGNlM2VlOWQ4ODFhZTUwZmQzYWI4YjU5NzhmZDI1ZTM4MzlhYWMxY2ZmNDlkZGJlIiwidGFnIjoiIn0%3Dwayfindertarget=eyJpdiI6InFuNW8rWC9zbDNHZUZZUGt6NGtNZGc9PSIsInZhbHVlIjoieTZMNTBlYk11RUhuQnRHdXZsVU1ZUFFyMHBoRTMyZFpqdHBCbDdvbUpGND0iLCJtYWMiOiI4YzI5ZDIyMGE4MzBl" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "alpha.eurekaselect.com" ] ]
        request_cookies
        0 of 0
        array:1 [ "wayfindertarget" => null ]
        response_headers
        0 of 0
        array:5 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Tue, 25 Feb 2025 04:36:45 GMT" ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6IjFXbHV1UXNVdm50NURuaElrZ3U0WWc9PSIsInZhbHVlIjoiR3NXK2JwRnhNTDgvS0FlNGRsYmxtaHg2VmFSaEtHQ3N2aUZTekJ3RW9pMS9oNjBmSlpkWnhjM1RuNmNIbUhidmJGNm5yWmZndE5kVkl1citQMFcweW5mN1dPSHVKYTZlaWw4Zkpqc1ZoT2hqRE9TYnFsYTJhQ1h6R0RWa0R4bEoiLCJtYWMiOiIwYjZiMTc1Yzk0NDIzMWYwYTQ5ZWI5NDViZmEyOTJlZTUzYTZkMDQ0ZjdlMGVmZmI5MWNiNjFlNDczNmNjN2UwIiwidGFnIjoiIn0%3D; expires=Thu, 27 Feb 2025 16:36:45 GMT; Max-Age=216000; path=/; secure; samesite=laxXSRF-TOKEN=eyJpdiI6IjFXbHV1UXNVdm50NURuaElrZ3U0WWc9PSIsInZhbHVlIjoiR3NXK2JwRnhNTDgvS0FlNGRsYmxtaHg2VmFSaEtHQ3N2aUZTekJ3RW9pMS9oNjBmSlpkWnhjM1RuNmNIbUhidmJGNm5yW" 1 => "alphaeurekaselectnet_session=eyJpdiI6InNlakZUSXVKdjl0NnFGZGZLbXBza0E9PSIsInZhbHVlIjoiRjk2K3VLSURBaGtncVl3cktHdjdTZEVsOEpGOFJZM0hDQ0lvbFZCaTRHbDdCMkVjcUJLZ1RyZXUwdDlhVlUwZzBZbDVPV21ZSVZBcE5QK2o1OHN6TnloZGZhS29Jbkx0WHJoUHpOZnRYMExhNWwzdnVwbTNsRDZQMTFoZURuVnoiLCJtYWMiOiIzNDJjY2YyNWY1NmM4ZGU1YTJlNzAyMjFiOTU1MmViYzRlNjRhNzcxNjZlMDJiZTJkNjk4NTY0M2EwYzAwZDliIiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=laxalphaeurekaselectnet_session=eyJpdiI6InNlakZUSXVKdjl0NnFGZGZLbXBza0E9PSIsInZhbHVlIjoiRjk2K3VLSURBaGtncVl3cktHdjdTZEVsOEpGOFJZM0hDQ0lvbFZCaTRHbDdCMkVjcUJLZ1RyZXU" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6IjFXbHV1UXNVdm50NURuaElrZ3U0WWc9PSIsInZhbHVlIjoiR3NXK2JwRnhNTDgvS0FlNGRsYmxtaHg2VmFSaEtHQ3N2aUZTekJ3RW9pMS9oNjBmSlpkWnhjM1RuNmNIbUhidmJGNm5yWmZndE5kVkl1citQMFcweW5mN1dPSHVKYTZlaWw4Zkpqc1ZoT2hqRE9TYnFsYTJhQ1h6R0RWa0R4bEoiLCJtYWMiOiIwYjZiMTc1Yzk0NDIzMWYwYTQ5ZWI5NDViZmEyOTJlZTUzYTZkMDQ0ZjdlMGVmZmI5MWNiNjFlNDczNmNjN2UwIiwidGFnIjoiIn0%3D; expires=Thu, 27-Feb-2025 16:36:45 GMT; path=/; secureXSRF-TOKEN=eyJpdiI6IjFXbHV1UXNVdm50NURuaElrZ3U0WWc9PSIsInZhbHVlIjoiR3NXK2JwRnhNTDgvS0FlNGRsYmxtaHg2VmFSaEtHQ3N2aUZTekJ3RW9pMS9oNjBmSlpkWnhjM1RuNmNIbUhidmJGNm5yW" 1 => "alphaeurekaselectnet_session=eyJpdiI6InNlakZUSXVKdjl0NnFGZGZLbXBza0E9PSIsInZhbHVlIjoiRjk2K3VLSURBaGtncVl3cktHdjdTZEVsOEpGOFJZM0hDQ0lvbFZCaTRHbDdCMkVjcUJLZ1RyZXUwdDlhVlUwZzBZbDVPV21ZSVZBcE5QK2o1OHN6TnloZGZhS29Jbkx0WHJoUHpOZnRYMExhNWwzdnVwbTNsRDZQMTFoZURuVnoiLCJtYWMiOiIzNDJjY2YyNWY1NmM4ZGU1YTJlNzAyMjFiOTU1MmViYzRlNjRhNzcxNjZlMDJiZTJkNjk4NTY0M2EwYzAwZDliIiwidGFnIjoiIn0%3D; path=/; secure; httponlyalphaeurekaselectnet_session=eyJpdiI6InNlakZUSXVKdjl0NnFGZGZLbXBza0E9PSIsInZhbHVlIjoiRjk2K3VLSURBaGtncVl3cktHdjdTZEVsOEpGOFJZM0hDQ0lvbFZCaTRHbDdCMkVjcUJLZ1RyZXU" ] ]
        session_attributes
        0 of 0
        array:5 [ "_token" => "y9w8k8zMnopb8xedSQfhab94v89NI5MCkqgj0tKl" "uc_cart_id" => "ead92e0c4a049ec07c18b3d243ca3b89" "_previous" => array:1 [ "url" => "http://alpha.eurekaselect.com/article/93685" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]
        ClearShow all
        Date ↕MethodURLData
        #12025-02-25 04:36:45GET/article/93685310351